Clinical Trial Update: Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause [Phase 1, Phase 2]

View source ↗

Summary

AbCellera Biologics is evaluating ABCL635 in a Phase 1/2 study for vasomotor symptoms of menopause; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms Associated with Menopause

Drugs mentioned

• ABCL635

Snippet

Sponsor: AbCellera Biologics Inc. | Conditions: Vasomotor Symptoms Associated With Menopause, Healthy Volunteers | Phase 1, Phase 2 | Status: RECRUITING